May 26, 2016  

 

EAS 2016, Innsbruck Austria

May 29 - June 01

Accredited Educational Programme

Attendees to the 84th EAS Congress are entitled to claim up to 15 EBAC credits for attending the main Congress programme of Plenary & Workshop sessions. Congress delegates can gain further EBAC credits by attending the following additional CME-accredited educational programmes.

These educational programmes are accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour (each) of external CME credit(s); Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

EAS have independently organised all matters related to these Programmes, including content and presenters. We acknowledge financial support, in the form of educational grants, received from industry supporters.

 

To the congress website >>


     

Diet and prevention of cardiovascular disease

Sunday May 29, 14:00 - 15:30

According to the guidelines, the first steps to treat patients with dyslipidemia are lifestyle recommendations. However these are difficult to implement on a long term basis. There are also new data on the role of fatty acids & sugar intake, as well as functional foods in the risk of cardiovascular disease. This educational programme is an important update to help physicians in their daily practice.

To this accredited educational session >>

 

 

Gene therapy and lipoprotein lipase deficiency
Sunday May 29, 14:00-15:00

Though not common, lipoprotein lipase deficiency is a severe clinical disorder. This educational programme provides important training for clinicians, highlighting state-of-the-art clinical management of this group of patients.

To this accredited educational session >>

 
 
 

Nutraceuticals with lipid lowering activity: who can benefit?
Monday May 30, 13:00 - 14:00

This educational programme will address gaps in knowledge in the rapidly evolving field of nutraceuticals – providing unbiased expert information, based on EAS-ESC guidelines and supported by recent clinical evidence.

To the this accredited educational programme >>

 
   

Low HDL high triglyceride, diabetic dyslipidaemia
Tuesday May 31

Although dyslipidaemia is well known as a treatable risk factor, focus has been on cholesterol. Recent research emphasises triglyceride rich lipoproteins as causative to atherosclerosis and cardiovascular disease. This educational programme’s focus is to address the knowledge gap in this area.

To this accredited educational programme >>

 
   

Lysosomal Acid Lipase Deficiency
Tuesday May 31, 13:00 - 14:00

A number of persons with LAL deficiency develop fatty liver or hyperdyslipidaemia, which can be corrected by modulating enzyme. This educational programme addresses issues concerning how to identify the right patient and what is the best treatment.

To this accredited educational programme >

 
     
 
Find out more

About this email


 

European Atherosclerosis Society © 2015



This email was sent to '@@email@@' from European Atherosclerosis Society.
If you wish to stop receiving email from us, you can simply remove yourself by visiting: @@unsubscribe_url@@